Berta, E.; Halmi, S.; Molnár, I.; Hutkai, D.; Csiha, S.; Bhattoa, H.P.; Lőrincz, H.; Somodi, S.; Katkó, M.; Harangi, M.;
et al. Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto’s Thyroiditis on Levothyroxine Substitution. Metabolites 2024, 14, 565.
https://doi.org/10.3390/metabo14100565
AMA Style
Berta E, Halmi S, Molnár I, Hutkai D, Csiha S, Bhattoa HP, Lőrincz H, Somodi S, Katkó M, Harangi M,
et al. Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto’s Thyroiditis on Levothyroxine Substitution. Metabolites. 2024; 14(10):565.
https://doi.org/10.3390/metabo14100565
Chicago/Turabian Style
Berta, Eszter, Sándor Halmi, István Molnár, Dávid Hutkai, Sára Csiha, Harjit Pal Bhattoa, Hajnalka Lőrincz, Sándor Somodi, Mónika Katkó, Mariann Harangi,
and et al. 2024. "Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto’s Thyroiditis on Levothyroxine Substitution" Metabolites 14, no. 10: 565.
https://doi.org/10.3390/metabo14100565
APA Style
Berta, E., Halmi, S., Molnár, I., Hutkai, D., Csiha, S., Bhattoa, H. P., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., & Bodor, M.
(2024). Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto’s Thyroiditis on Levothyroxine Substitution. Metabolites, 14(10), 565.
https://doi.org/10.3390/metabo14100565
